AVDL - Avadel Pharmaceuticals plc (AVDL) CEO Greg Divis on Q1 2020 Results - Earnings Call Transcript
Avadel Pharmaceuticals plc (AVDL)
Q1 2020 Earnings Conference Call
May 11, 2020 08:30 AM ET
Company Participants
Thomas McHugh - Chief Financial Officer
Greg Divis - Chief Executive Officer
Jordan Dubow - Chief Medical Officer
Conference Call Participants
David Amsellem - Piper Sandler
Paul Matthews - Stifel
Francois Brisebois - Craig-Hallum Capital Group
Matt Kaplan - Ladenburg Thalmann
Presentation
Operator
Greetings, and welcome to the Avadel Pharmaceuticals’ First Quarter 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions]